Is there a role for mannan/mannose-binding lectin (MBL) in defence against infection following chemotherapy for cancer?
Klein
N J
NJ
Institute of Child Health, University College London, London, UK. nklein@ich.ucl.ac.uk
Kilpatrick
D C
DC
D000970:Antineoplastic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D001424:Bacterial Infections / Q000276:immunology* / Q000517:prevention & control; D004198:Disease Susceptibility; D006801:Humans; D037601:Mannose-Binding Lectin / Q000235:genetics / Q000276:immunology*; D009181:Mycoses / Q000276:immunology* / Q000517:prevention & control; D009369:Neoplasms / Q000188:drug therapy*; D009503:Neutropenia / Q000139:chemically induced / Q000276:immunology
D000970:Antineoplastic Agents; D037601:Mannose-Binding Lectin